Your browser doesn't support javascript.
loading
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis.
Littera, Roberto; Perra, Andrea; Miglianti, Michela; Piras, Ignazio S; Mocci, Stefano; Lai, Sara; Melis, Maurizio; Zolfino, Teresa; Balestrieri, Cinzia; Conti, Maria; Serra, Giancarlo; Figorilli, Francesco; Firinu, Davide; Onali, Simona; Matta, Laura; Porcu, Carmen; Pes, Francesco; Fanni, Daniela; Manieli, Cristina; Vacca, Monica; Cusano, Roberto; Trucas, Marcello; Cipri, Selene; Tranquilli, Stefania; Rassu, Stefania; Cannas, Federica; Carta, Mauro Giovanni; Kowalik, Marta Anna; Giuressi, Erika; Faa, Gavino; Chessa, Luchino; Giglio, Sabrina.
Afiliação
  • Littera R; Medical Genetics, R. Binaghi Hospital, Sardegna, Italy.
  • Perra A; AART-ODV (Association for the Advancement of Research on Transplantation), Cagliari, Italy.
  • Miglianti M; AART-ODV (Association for the Advancement of Research on Transplantation), Cagliari, Italy.
  • Piras IS; Section of Pathology, Oncology and Molecular Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Mocci S; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Lai S; Neurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ, United States.
  • Melis M; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Zolfino T; Medical Genetics, R. Binaghi Hospital, Sardegna, Italy.
  • Balestrieri C; AART-ODV (Association for the Advancement of Research on Transplantation), Cagliari, Italy.
  • Conti M; Division of Gastroenterology, Azienda di Rilievo Nazionale ed Alta Specializzazione (ARNAS), S. Michele Hospital, Cagliari, Italy.
  • Serra G; Liver Unit, University Hospital, Cagliari, Italy.
  • Figorilli F; Liver Unit, University Hospital, Cagliari, Italy.
  • Firinu D; Liver Unit, University Hospital, Cagliari, Italy.
  • Onali S; Division of Gastroenterology, Azienda di Rilievo Nazionale ed Alta Specializzazione (ARNAS), S. Michele Hospital, Cagliari, Italy.
  • Matta L; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Porcu C; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Pes F; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Fanni D; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Manieli C; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Vacca M; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital San Giovanni di Dio, Cagliari, Italy.
  • Cusano R; Department of Pathological Anatomy, Azienda di Rilievo Nazionale ed Alta Specializzazione (ARNAS), S. Michele Hospital, Cagliari, Italy.
  • Trucas M; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Cipri S; Biomedical Sector, Center for Advanced Studies, Research and Development (CRS4), Cagliari, Italy.
  • Tranquilli S; Section of Pathology, Oncology and Molecular Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Rassu S; AART-ODV (Association for the Advancement of Research on Transplantation), Cagliari, Italy.
  • Cannas F; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Carta MG; Medical Genetics, R. Binaghi Hospital, Sardegna, Italy.
  • Kowalik MA; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Giuressi E; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Faa G; Section of Pathology, Oncology and Molecular Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Chessa L; Medical Genetics, R. Binaghi Hospital, Sardegna, Italy.
  • Giglio S; Division of Pathology, Department of Medical Sciences and Public Health, University Hospital San Giovanni di Dio, Cagliari, Italy.
Front Immunol ; 13: 1007647, 2022.
Article em En | MEDLINE | ID: mdl-36311782
ABSTRACT
The immunomodulatory effects of HLA-G expression and its role in cancers, human liver infections and liver transplantation are well documented, but so far, there are only a few reports addressing autoimmune liver diseases, particularly autoimmune hepatitis (AIH). Method and materials We analyzed the genetic and phenotypic characteristics of HLA-G in 205 type 1 AIH patients (AIH-1) and a population of 210 healthy controls from Sardinia (Italy).

Results:

Analysis of the HLA-G locus showed no substantial differences in allele frequencies between patients and the healthy control population. The HLA-G UTR-1 haplotype was the most prevalent in both AIH-1 patients and controls (40.24% and 34.29%). Strong linkage was found between the HLA-G UTR-1 haplotype and HLA-DRB1*0301 in AIH-1 patients but not controls (D' = 0.92 vs D' = 0.50 respectively; P = 1.3x10-8). Soluble HLA-G (sHLA-G) levels were significantly lower in AIH-1 patients compared to controls [13.9 (11.6 - 17.4) U/mL vs 21.3 (16.5 - 27.8) U/mL; P = 0.011]. Twenty-four patients with mild or moderate inflammatory involvement, as assessed from liver biopsy, showed much higher sHLA-G levels compared to the 28 patients with severe liver inflammation [33.5 (23.6 - 44.8) U/mL vs 8.8 (6.1 - 14.5) U/mL; P = 0.003]. Finally, immunohistochemistry analysis of 52 liver biopsies from AIH-1 patients did not show expression of HLA-G molecules in the liver parenchyma. However, a percentage of 69.2% (36/52) revealed widespread expression of HLA-G both in the cytoplasm and the membrane of plasma cells labeled with anti-HLA-G monoclonal antibodies.

Conclusion:

This study highlights the positive immunomodulatory effect of HLA-G molecules on the clinical course of AIH-1 and how this improvement closely correlates with plasma levels of sHLA-G. However, our results open the debate on the ambiguous role of HLA-G molecules expressed by plasma cells, which are pathognomonic features of AIH-1.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite Autoimune Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite Autoimune Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália